EUVIMEDEUVIMED entdecken
Crossref

Serous‐like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumours

Gregor Krings iD, Eliah R Shamir iD, Marick Laé iD, Gregory R Bean iD, Miriam D Post iD, Stuart J Schnitt, Yunn-Yi Chen iD

Histopathology · 2025

DOI: 10.1111/his.15385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2025. Verfasst von Gregor Krings und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Cystadenocarcinoma, Serous. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Unusual morphologic patterns of breast carcinomas can raise diagnostic consideration for metastasis or special breast cancer subtypes with management implications. We describe rare invasive breast cancers that mimic serous carcinoma of the gynaecologic tract (serous‐like breast carcinomas, SLBC) and characterize their clinicopathologic, immunophenotypic, and genetic features. Methods and Results All patients were female ( n = 15, median age 49 years) without a history of gynaecologic malignancy. SLBC were characterized histologically by angulated, branched, sometimes anastomosing glands with micropapillary and/or pseudopapillary luminal projections in desmoplastic stroma. Most SLBC were triple‐negative (TN, n = 10) or HER2‐positive ( n = 2) and grade 2 or 3, while some were oestrogen receptor (ER) low‐positive/HER2‐negative and low‐grade ( n = 3). CK5/6 was positive irrespective of grade or receptor status (10/10). All SLBC expressed GATA3 (14/15), TRPS1 (7/7), and/or mammaglobin (4/13). SOX10 was positive in most TN (9/10) and all ER low‐positive (3/3) cases, but negative in HER2‐positive tumours. WT1 was universally negative, and PAX8 was focal in one mammaglobin‐positive tumour. All ER‐negative SLBC were p53‐aberrant and 9/11 were p16‐aberrant, whereas ER‐positive tumours were wildtype for both markers (3/3). TP53 was the only frequently mutated gene, altered in all ER‐negative (10/10) but no ER‐positive (0/4) tumours. Clinical behaviour was variable. Only 1/6 patients achieved pathologic complete response to neoadjuvant chemotherapy.

Conclusion

SLBC is a rare morphologic pattern of invasive breast carcinoma that mimics metastatic serous gynaecologic carcinoma, a potential diagnostic pitfall. SLBC are heterogeneous with respect to grade, receptor profile, and oncogenic driver alterations, without specific genetic underpinnings identified. Additional studies are warranted to further evaluate the clinical behaviour of these tumours.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCystadenocarcinoma, SerousHumansFemaleMiddle AgedAdultAgedBiomarkers, TumorImmunophenotypingDiagnosis, DifferentialAged, 80 and over

Stichwörter der Autor:innen

breast cancerinvasive ductal carcinomanext‐generation sequencingp16p53serous carcinoma

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, University of California San Francisco, San Francisco, California, USA.
  • Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Pathology, Centre Henri Becquerel, Rouen, France.
  • Department of Pathology, Stanford University, Stanford, California, USA.
  • Department of Pathology, University of Colorado, Aurora, Colorado, USA.
  • Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Breast Oncology Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

ORCID-Profile: Gregor Krings, Eliah R Shamir, Marick Laé, Gregory R Bean, Miriam D Post, Yunn-Yi Chen

Zitieren

APA

Krings, G., Shamir, E. R., Laé, M., Bean, G. R., Post, M. D., Schnitt, S. J., & Chen, Y. Y. (2025). Serous‐like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumours. Histopathology. https://doi.org/10.1111/his.15385

Vancouver

Krings G, Shamir ER, Laé M, Bean GR, Post MD, Schnitt SJ, et al. Serous‐like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumours. Histopathology. 2025. doi:10.1111/his.15385

BibTeX
@article{Krings2025,
  author = {Krings, Gregor and Shamir, Eliah R and Laé, Marick and Bean, Gregory R and Post, Miriam D and Schnitt, Stuart J and Chen, Yunn-Yi},
  title = {Serous‐like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumours},
  journal = {Histopathology},
  year = {2025},
  doi = {10.1111/his.15385}
}
Kostenlos starten →